TATX-03

N/A

Report date: 2024/01/02 16:18:46

Base Information

Drug NameTATX-03
Drug Alias NameTATX-03 PolyTope™ Therapyanti-SARS-CoV-2 PolyTope (Talem Therapeutics)TATX-03TATX-03E
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Coronavirus spike glycoprotein
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesElektrofi IncTalem Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A